Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis

BACKGROUND: Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system and is one of the leading causes of disability in young adults. Cell therapy is emerging as a therapeutic strategy to promote repair and regeneration in patients with disability associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Violaine K., Stark, James, Vyshkina, Tamara, Blackshear, Leslie, Joo, Gloria, Stefanova, Valentina, Sara, Gabriel, Sadiq, Saud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925446/
https://www.ncbi.nlm.nih.gov/pubmed/29449193
http://dx.doi.org/10.1016/j.ebiom.2018.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925446/
https://www.ncbi.nlm.nih.gov/pubmed/29449193
http://dx.doi.org/10.1016/j.ebiom.2018.02.002

Ejemplares similares